These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25966997)

  • 1. Differences between glioblastomas and primary central nervous system lymphomas in 1H-magnetic resonance spectroscopy.
    Aburano H; Ueda F; Yoshie Y; Matsui O; Nakada M; Hayashi Y; Gabata T
    Jpn J Radiol; 2015 Jul; 33(7):392-403. PubMed ID: 25966997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy.
    Harting I; Hartmann M; Jost G; Sommer C; Ahmadi R; Heiland S; Sartor K
    Neurosci Lett; 2003 May; 342(3):163-6. PubMed ID: 12757890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.
    Toh CH; Wei KC; Chang CN; Ng SH; Wong HF
    AJNR Am J Neuroradiol; 2013; 34(6):1145-9. PubMed ID: 23348763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma.
    Nagashima H; Sasayama T; Tanaka K; Kyotani K; Sato N; Maeyama M; Kohta M; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
    J Neurooncol; 2018 Jan; 136(2):317-326. PubMed ID: 29143277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.
    Chawla S; Zhang Y; Wang S; Chaudhary S; Chou C; O'Rourke DM; Vossough A; Melhem ER; Poptani H
    J Comput Assist Tomogr; 2010; 34(6):836-41. PubMed ID: 21084897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
    Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
    J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusion-weighted MRI.
    Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K
    Clin Radiol; 2015 Dec; 70(12):1393-9. PubMed ID: 26382744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
    Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
    Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.
    Makino K; Hirai T; Nakamura H; Kuroda JI; Shinojima N; Uetani H; Kitajima M; Yano S
    World Neurosurg; 2018 Apr; 112():e1-e6. PubMed ID: 29104150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short TE single-voxel 1H-MR spectroscopy of hippocampal structures in healthy adults at 1.5 Tesla--how reproducible are the results?
    Hammen T; Stadlbauer A; Tomandl B; Ganslandt O; Pauli E; Huk W; Neundörfer B; Stefan H
    NMR Biomed; 2005 May; 18(3):195-201. PubMed ID: 15884101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional distributions of brain glutamate and glutamine in normal subjects.
    Goryawala MZ; Sheriff S; Maudsley AA
    NMR Biomed; 2016 Aug; 29(8):1108-16. PubMed ID: 27351339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating Primary Central Nervous System Lymphomas From Glioblastomas and Inflammatory Demyelinating Pseudotumor Using Relative Minimum Apparent Diffusion Coefficients.
    Wen JB; Huang WY; Xu WX; Wu G; Geng DY; Yin B
    J Comput Assist Tomogr; 2017; 41(6):904-909. PubMed ID: 28708728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion kurtosis imaging differs between primary central nervous system lymphoma and high-grade glioma and is correlated with the diverse nuclear-to-cytoplasmic ratio: a histopathologic, biopsy-based study.
    Haopeng P; Xuefei D; Yan R; Zhenwei Y; Wei H; Ziyin W; Qungang S; Chaojie L; Linyan Y; Zhongmin W; Xiaoyuan F
    Eur Radiol; 2020 Apr; 30(4):2125-2137. PubMed ID: 31858206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute and late CNS glutamine response to benzodiazepine challenge: a pilot pharmacokinetic study using proton magnetic resonance spectroscopy.
    Henry ME; Jensen JE; Licata SC; Ravichandran C; Butman ML; Shanahan M; Lauriat TL; Renshaw PF
    Psychiatry Res; 2010 Dec; 184(3):171-6. PubMed ID: 21055907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
    Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
    Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging.
    Suh CH; Kim HS; Lee SS; Kim N; Yoon HM; Choi CG; Kim SJ
    Radiology; 2014 Aug; 272(2):504-13. PubMed ID: 24697149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue].
    Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.